Current role
Kristen K. Buck
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Kristen K. Buck
Lisata Therapeutics, Inc. reported in an 8-K filed September 15, 2022 that Kristen K. Buck was appointed Executive Vice President of R&D and Chief Medical Officer, effective September 15, 2022. The proxy statement of Lisata Therapeutics, Inc. reports total compensation of $1,065,061 for Kristen K. Buck in fiscal 2024, including a base salary of $597,421. Disclosed compensation is on record for 4 fiscal years.
“Kristen K. Buck, M.D., current Executive Vice President of R&D and Chief Medical Officer of Caladrius, will continue in those roles with Lisata.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lisata Therapeutics, Inc. (LSTA)
Proxy statement
Current2022-09-15–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lisata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Mazzo CEO, Board Member
- David J. Mazzo, Ph.D. CEO
- David Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $597,421 | $1,065,061 |
| 2023 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $574,443 | $969,817 |
| 2022 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $553,781 | $1,124,102 |
| 2021 | Lisata Therapeutics, Inc. (LSTA) | M.D, Executive Vice President of Research & Development and Chief Medical Officer | $183,333 | $1,858,333 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.